Shuai Yue
Cancer Center,
Daping Hospital & Army Medical Center of PLA,
Cancer Center, Daping Hospital & Army Medical Center of PLA
Third Military Medical University
Shuai Yue has not added Biography.
If you are Shuai Yue and would like to personalize this page please email our Author Liaison for assistance.
Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
Signal transduction and targeted therapy 09, 2020 | Pubmed ID: 32879307
The Epigenetic Regulator EZH2 Instructs CD4 T Cell Response to Acute Viral Infection via Coupling of Cell Expansion and Metabolic Fitness.
Journal of virology 11, 2020 | Pubmed ID: 32999031
The lncRNA Snhg1-Vps13D vesicle trafficking system promotes memory CD8 T cell establishment via regulating the dual effects of IL-7 signaling.
Signal transduction and targeted therapy 03, 2021 | Pubmed ID: 33758164
Sensitivity of SARS-CoV-2 Variants to Neutralization by Convalescent Sera and a VH3-30 Monoclonal Antibody.
Frontiers in immunology , 2021 | Pubmed ID: 34630430
Differential expression of inhibitory receptor NKG2A distinguishes disease-specific exhausted CD8 T cells.
MedComm Mar, 2022 | Pubmed ID: 35281793
A potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD.
Signal transduction and targeted therapy Apr, 2022 | Pubmed ID: 35383141
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope.
Cell host & microbe Jun, 2022 | Pubmed ID: 35436443
Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern: A Small-Scale Clinical Trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Feb, 2023 | Pubmed ID: 35666466
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness.
Vaccine Jul, 2023 | Pubmed ID: 37400286
An oncolytic virus delivering tumor-irrelevant bystander T cell epitopes induces anti-tumor immunity and potentiates cancer immunotherapy.
Nature cancer Apr, 2024 | Pubmed ID: 38609488
Accessing Early Differentiation of Virus-Specific Follicular Helper CD4+ T Cell in Acute LCMV-Infected Mice
1Department of Urology, South China Hospital, Medical School, Shenzhen University,
2Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School,
3Cancer Center, Daping Hospital & Army Medical Center of PLA, Third Military Medical University,
4Guangdong Provincial Key Laboratory of Immune Regulation and Immunotherapy, School of Laboratory Medicine and Biotechnology, Southern Medical University,
5Institute of Immunology, Third Military Medical University,
6Dermatology Hospital, Southern Medical University,
7Institute of Immunological Innovation and Translation, Chongqing Medical University
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유